Mumbai, India – 8 May 2025 – Sudarshan Pharma Industries Ltd (BSE: 543828), a rapidly growing player in the pharmaceutical and specialty chemicals sector, is actively seeking to acquire or partner with a modern Chemical or Active Pharmaceutical Ingredient (API) manufacturing facility as part of its aggressive expansion and integration […]